アルボウイルス検査市場- 世界の産業規模、シェア、動向、機会、予測、検査タイプ別、エンドユーザー別、地域別、競合別、2019年～2029年

世界のアルボウイルス検査市場は、2023年に11億5,000万米ドルと評価され、予測期間では2029年までCAGR 5.72%で堅調な成長が予測されています。

アルボウイルス検査の世界市場は、世界のアルボウイルスの脅威の増加により、世界のヘルスケア分野で不可欠な要素となっています。アルボウイルスは、主に蚊やダニのような昆虫によって媒介され、重篤でしばしば致命的な人体疾患につながる可能性があるため、懸念が高まっています。この市場は、ヘルスケア・システムがこれらのウイルス感染を効果的に特定し管理するための診断能力の強化を目指していることから、顕著な成長を遂げています。市場拡大の主な促進要因としては、アルボウイルス疾患の発生率の増加、ヘルスケア専門家の意識の高まり、正確でタイムリーな診断の緊急ニーズなどが挙げられます。世界各国の政府やヘルスケア機関は、迅速かつ正確な結果を提供する革新的な検査法を導入するための研究開発に投資しています。分子診断、血清学的検査、核酸増幅技術などの先端技術が活用され、感度と特異性が向上しています。アルボウイルスの発生が多い地域、特にアジア太平洋、ラテンアメリカ、アフリカでは、アルボウイルス検査ソリューションに対する需要が高まっています。さらに、アルボウイルスを含む媒介性疾患と闘うための世界の取り組みが、効果的な検査戦略を開発・展開するための医療機関、研究機関、診断企業間の連携を促進しています。世界のアルボウイルス検査市場が拡大を続ける中、業界各社は競争優位性を獲得するため、製品のイノベーション、戦略的パートナーシップ、新たな地域への進出に注力しています。アルボウイルス診断におけるテクノロジーとヘルスケアの統合は、これらの感染症がもたらす課題に対処する上で大きな進歩を意味し、最終的には世界の公衆衛生の向上に貢献します。

市場促進要因

アルボウイルス疾患の発生率の上昇

意識の高まりと教育

診断技術の進歩

主な市場課題

資源が限られた環境での限られたアクセシビリティ

一般市民の認識と教育のギャップ

主な市場動向

研究開発の増加

世界のサーベイランスとモニタリング

セグメント別の洞察

検査タイプ別の洞察

地域別の洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 アルボウイルス検査の世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別（RT-PCR検査、ELISA検査）
  • エンドユーザー別（病院、診断センター）
  • 地域別
  • 企業別（2023年）
• 市場マップ
  • 検査タイプ別
  • エンドユーザー別
  • 地域別

第6章 アジア太平洋地域のアルボウイルス検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州のアルボウイルス検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米のアルボウイルス検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• 北米国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米のアルボウイルス検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのアルボウイルス検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のアルボウイルス検査市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Becton Dickinson & Co
• bioMerieux SA
• Abbott Laboratories Inc.
• Quidel Corporation
• OraSure Technologies, Inc.
• Hologic Inc.（Gen Probe）
• Cepheid（Danaher）
• QIAGEN N. V.
• F. Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Arbovirus Testing Market was valued at USD 1.15 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 5.72% through 2029. The Global Arbovirus Testing Market has become a vital element in the worldwide healthcare sector due to the increasing threat of arboviruses globally. Arboviruses, primarily transmitted by insects like mosquitoes and ticks, pose a rising concern as they can lead to severe and often fatal human diseases. This market is experiencing notable growth as healthcare systems aim to enhance their diagnostic capabilities for effectively identifying and managing these viral infections. Key drivers for the expansion of the market include the growing incidence of arboviral diseases, heightened awareness among healthcare professionals, and the urgent need for precise and timely diagnostics. Governments and healthcare organizations worldwide are investing in research and development to introduce innovative testing methods that offer rapid and accurate results. Advanced technologies such as molecular diagnostics, serological tests, and nucleic acid amplification techniques are being utilized, providing enhanced sensitivity and specificity. Regions with higher occurrences of arbovirus outbreaks, particularly Asia-Pacific, Latin America, and Africa, are witnessing strong demand for arbovirus testing solutions. Additionally, global efforts to combat vector-borne diseases, including arboviruses, are driving collaborations between healthcare institutions, research bodies, and diagnostic companies to develop and deploy effective testing strategies. As the Global Arbovirus Testing Market continues to progress, industry players are focusing on product innovation, strategic partnerships, and expanding into new geographical areas to gain a competitive advantage. The integration of technology and healthcare in arbovirus diagnostics represents a significant advancement in addressing the challenges posed by these infectious diseases, ultimately contributing to the enhancement of public health worldwide.

Key Market Drivers

Rising Incidence of Arboviral Diseases

The escalating incidence of arboviral diseases has emerged as a compelling catalyst driving the growth of the Global Arbovirus Testing Market. Arboviruses, transmitted primarily by arthropods like mosquitoes and ticks, pose a significant public health threat globally. The rising prevalence of diseases such as Dengue fever, Zika virus, Chikungunya, and West Nile virus has prompted a critical need for robust diagnostic solutions. As climate change, urbanization, and global travel continue to create favorable conditions for the spread of arboviruses, the frequency and geographic distribution of these diseases are on the rise. This upsurge in cases not only contribute to an increased healthcare burden but also underscores the imperative for timely and accurate diagnostic tools. The demand for arbovirus testing is further intensified by the severity of these infections, which can range from mild symptoms to life-threatening complications. Healthcare systems worldwide are recognizing the urgency of implementing effective testing strategies to identify and manage arboviral diseases promptly. Consequently, the market is witnessing a surge in research and development efforts to enhance diagnostic technologies, including molecular diagnostics and nucleic acid amplification techniques. The synergy between the rising incidence of arboviral diseases and the advancements in testing methodologies underscores the pivotal role of the Global Arbovirus Testing Market in mitigating the impact of these infectious diseases and safeguarding public health on a global scale.

Growing Awareness and Education

The Global Arbovirus Testing Market is experiencing a significant impetus from the growing awareness and education initiatives surrounding arboviral diseases. As the incidence of diseases like Zika virus, Dengue fever, Chikungunya, and West Nile virus continues to rise, there has been a concerted effort to educate healthcare professionals, governments, and the general public about the risks and consequences of these infections. Awareness campaigns, public health programs, and educational outreach activities play a crucial role in disseminating information about the transmission, symptoms, and prevention of arboviruses. This increased awareness has led to a proactive approach toward arbovirus testing, with individuals and healthcare providers recognizing the importance of early detection and timely intervention. Healthcare professionals are equipped with the knowledge to identify symptoms, understand transmission patterns, and implement appropriate testing strategies. Governments and health organizations are actively supporting these educational efforts, contributing to a more informed and vigilant population. This heightened awareness is translating into a growing demand for arbovirus testing solutions, as individuals and healthcare systems recognize the need for accurate and efficient diagnostic tools to manage and control the spread of these infectious diseases. The synergy between growing awareness and the uptake of arbovirus testing underscores the vital role of education in shaping a proactive and responsive approach to combatting arboviral diseases on a global scale.

Advancements in Diagnostic Technologies

Advancements in diagnostic technologies are playing a pivotal role in propelling the Global Arbovirus Testing Market forward. As arboviral diseases pose an increasing global health threat, continuous innovation in diagnostic methodologies is enhancing the precision and efficiency of arbovirus testing. Molecular diagnostics, serological tests, and nucleic acid amplification techniques are at the forefront of these technological advancements. These sophisticated testing methods provide healthcare professionals with highly sensitive and specific tools for the rapid detection and accurate diagnosis of arboviral infections. The utilization of molecular techniques, such as polymerase chain reaction (PCR), enables the identification of viral genetic material, allowing for early and precise detection even in cases with low viral loads. Serological tests, including enzyme-linked immunosorbent assays (ELISA), contribute to the identification of antibodies produced in response to arboviral infections, aiding in both diagnosis and surveillance efforts. Additionally, nucleic acid amplification techniques amplify and detect viral RNA or DNA, enhancing the sensitivity of testing methodologies. The integration of point-of-care testing and portable diagnostic devices further facilitates the timely identification of arboviral infections, especially in resource-limited settings. These technological advancements not only expedite the diagnostic process but also contribute to more efficient and targeted public health interventions. As the Global Arbovirus Testing Market evolves, the continuous progress in diagnostic technologies is expected to drive the market's expansion, enabling healthcare systems to respond more effectively to the challenges posed by arboviral diseases and ultimately improving patient outcomes.

Key Market Challenges

Limited Accessibility in Resource-Limited Settings

Limited accessibility in resource-limited settings stands out as a significant challenge for the Global Arbovirus Testing Market. Regions that are most vulnerable to arboviral diseases often grapple with insufficient healthcare infrastructure, inadequate funding, and a shortage of skilled personnel. These resource constraints hinder the widespread availability and adoption of advanced arbovirus testing solutions. In many instances, remote and underserved areas lack the necessary laboratory facilities and trained personnel to administer and interpret complex diagnostic tests. The absence of basic healthcare amenities in resource-limited settings exacerbates the challenge, hindering the prompt identification and management of arboviral infections. Access to cutting-edge diagnostic technologies, such as molecular tests and nucleic acid amplification techniques, is often limited in these areas, leading to delayed or inaccurate diagnoses. The logistical challenges associated with transporting samples to centralized testing facilities further contribute to the difficulties faced by healthcare systems in such settings. Efforts to address limited accessibility in resource-limited settings require a multi-faceted approach. This includes the development of point-of-care testing devices that are portable, user-friendly, and do not require sophisticated infrastructure. These devices can empower healthcare workers in remote areas to conduct rapid and on-site arbovirus testing, facilitating timely intervention and reducing the burden on centralized laboratories. Collaborative initiatives involving governments, non-governmental organizations, and international bodies are crucial to overcoming the barriers posed by limited resources. Funding and support for capacity-building programs, training healthcare personnel, and establishing sustainable healthcare infrastructures can contribute to enhancing accessibility to arbovirus testing in resource-limited settings. Ultimately, addressing these challenges is essential to ensuring that the benefits of advanced arbovirus testing are extended to populations in need, irrespective of their geographical or economic circumstances.

Public Awareness and Education Gaps

Public awareness and education gaps constitute a significant challenge for the Global Arbovirus Testing Market. Despite the increasing prevalence of arboviral diseases worldwide, there remains a substantial lack of awareness among the general public regarding the risks, symptoms, and preventive measures associated with these infections. Inadequate understanding of arboviruses and their potential impact on public health leads to a delay in seeking medical attention and contributes to the underutilization of arbovirus testing services. Education gaps are not limited to the general public but also extend to healthcare professionals. Misdiagnosis and delayed testing may occur due to insufficient knowledge about the nuances of arboviral diseases, leading to the potential for unchecked transmission and increased morbidity. Addressing these knowledge gaps is crucial to ensure the effective implementation of arbovirus testing strategies. Improving public awareness requires targeted and comprehensive educational campaigns. Governments, healthcare organizations, and advocacy groups play a pivotal role in disseminating information about arboviral diseases, transmission patterns, and the significance of early detection. These campaigns should emphasize the availability and importance of arbovirus testing in preventing the spread of infections and mitigating their impact on individuals and communities. Additionally, healthcare professionals need continuous education and training to stay abreast of the latest developments in arbovirus diagnostics. Collaborative efforts between public health agencies, academic institutions, and medical associations can help bridge the education gaps, ensuring that healthcare providers are well-equipped to recommend and administer appropriate arbovirus testing. Ultimately, addressing public awareness and education gaps is integral to unlocking the full potential of the Global Arbovirus Testing Market. A well-informed public and healthcare workforce will be more proactive in seeking and providing testing services, contributing to early detection, efficient management of arboviral diseases, and the overall improvement of public health outcomes on a global scale.

Key Market Trends

Increased Research and Development

Increased Research and Development (R&D) activities have emerged as a critical driver in advancing the Global Arbovirus Testing Market. The rising incidence of arboviral diseases and the evolving nature of these viruses have propelled the need for more accurate, sensitive, and rapid diagnostic solutions. Research and development efforts within the arbovirus testing sector focus on enhancing existing technologies and innovating new methodologies to meet the growing demands of healthcare systems globally. One notable trend in R&D is the exploration and refinement of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleic acid amplification. These techniques enable the detection of viral genetic material with high sensitivity, providing a valuable tool for early and precise identification of arboviral infections. Additionally, there is a concerted effort to develop point-of-care testing devices that are portable, user-friendly, and suitable for use in resource-limited settings. Such devices empower healthcare professionals to conduct rapid on-site testing, facilitating timely intervention and containment of outbreaks. Collaborations between research institutions, diagnostic companies, and government agencies have played a pivotal role in fostering innovation. These partnerships leverage combined expertise and resources to accelerate the development of cutting-edge testing methodologies. Furthermore, increased funding for arbovirus-related research initiatives has allowed for a more comprehensive understanding of these viruses and the identification of potential therapeutic targets. The integration of artificial intelligence (AI) and machine learning in arbovirus testing is another facet of R&D gaining prominence. These technologies aid in data analysis, interpretation, and prediction, contributing to improved diagnostic accuracy and efficiency. As the Global Arbovirus Testing Market continues to evolve, the commitment to ongoing research and development activities remains crucial. Advancements in technology and diagnostic capabilities resulting from these efforts are pivotal in the global fight against arboviral diseases, enabling healthcare systems to better understand, detect, and manage these infectious threats.

Global Surveillance and Monitoring

Global surveillance and monitoring initiatives are pivotal in shaping the trajectory of the Global Arbovirus Testing Market. The persistent threat of arboviral diseases, including Zika virus, Dengue fever, Chikungunya, and West Nile virus, has led to intensified efforts to establish comprehensive surveillance systems worldwide. Governments, public health organizations, and research institutions are making substantial investments in monitoring arbovirus spread and prevalence to detect outbreaks early and implement timely interventions.

A crucial aspect of global surveillance is establishing robust reporting systems for arboviral infections. Timely and accurate data collection enables the identification of trends, hotspots, and potential areas of concern. These surveillance systems integrate epidemiological data, laboratory results, and environmental factors to provide a holistic view of arbovirus activity. Advanced technologies such as geographic information systems (GIS) and remote sensing have significantly enhanced global surveillance capabilities. These tools facilitate mapping and tracking of arbovirus transmission patterns, aiding authorities in anticipating and responding to potential outbreaks. Real-time data sharing and collaboration between countries and international health organizations contribute to a collective and coordinated global response.

The information gathered through surveillance efforts plays a crucial role in shaping arbovirus testing strategies. It informs resource allocation, deployment of testing facilities, and development of targeted testing protocols. Insights from global monitoring also drive continuous improvement of diagnostic tools and methodologies, ensuring their effectiveness across diverse geographical and epidemiological contexts. As the Global Arbovirus Testing Market evolves, the synergy between surveillance, monitoring, and testing becomes increasingly evident. These interconnected efforts foster a proactive approach to arboviral disease management, aiming to minimize the impact of outbreaks and protect public health worldwide. Collaboration and information-sharing facilitated by global surveillance mechanisms significantly enhance the overall effectiveness of arbovirus testing strategies.

Segmental Insights

Test Type Insights

Based on test type, ELISA tests segment dominated the Global Arbovirus Testing Market in 2023. This is ascribed due to its high sensitivity, specificity, and efficiency in detecting arboviral infections. Enzyme-Linked Immunosorbent Assay (ELISA) tests provide a reliable and cost-effective method for identifying antibodies or antigens associated with arboviruses. ELISA's ability to detect a diverse range of arboviruses and its widespread adoption in diagnostic laboratories contribute to its market dominance. Moreover, ELISA's scalability and suitability for large-scale screening during outbreaks enhance its appeal for arbovirus testing, solidifying its position as a preferred and effective diagnostic tool in the global market.

Regional Insights

North America holds the largest share in the Global Arbovirus Testing Market due to robust healthcare infrastructure, advanced diagnostic technologies, and high awareness levels. The region faces significant arbovirus threats, such as West Nile virus and Zika virus, prompting extensive testing initiatives. Well-established research facilities and collaborations between government agencies and private sectors contribute to cutting-edge testing capabilities. Additionally, proactive public health measures and stringent regulatory frameworks enhance testing protocols. The prevalence of competent vectors and periodic outbreaks further underscores the need for comprehensive arbovirus testing in North America, consolidating its leadership position in addressing and managing arbovirus-related public health challenges.

Key Market Players

Becton Dickinson & Co

bioMerieux SA

Abbott Laboratories Inc.

Quidel Corporation

OraSure Technologies, Inc.

Hologic Inc. (Gen Probe)

Cepheid (Danaher)

QIAGEN N. V.

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories, Inc.

Report Scope:

In this report, the Global Arbovirus Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Arbovirus Testing Market, By Test Type:

RT-PCR Test ELISA-Test

Arbovirus Testing Market, By End User:

Hospitals Diagnostic Centers

Arbovirus Testing Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Arbovirus Testing Market.

Available Customizations:

Global Arbovirus Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Arbovirus Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (RT-PCR Test, ELISA-Test)
  • 5.2.2. By End User (Hospitals, Diagnostic Centers)
  • 5.2.3. By Region
  • 5.2.4. By Company (2023)
• 5.3. Market Map
  • 5.3.1. By Test Type
  • 5.3.2. By End User
  • 5.3.3. By Region

6. Asia Pacific Arbovirus Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Arbovirus Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By End User
  • 6.3.2. India Arbovirus Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Australia Arbovirus Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By End User
  • 6.3.4. Japan Arbovirus Testing Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Test Type
      • 6.3.4.2.2. By End User
  • 6.3.5. South Korea Arbovirus Testing Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Test Type
      • 6.3.5.2.2. By End User

7. Europe Arbovirus Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Arbovirus Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Arbovirus Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Spain Arbovirus Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Arbovirus Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By End User
  • 7.3.5. United Kingdom Arbovirus Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By End User

8. North America Arbovirus Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Arbovirus Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Mexico Arbovirus Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Canada Arbovirus Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By End User

9. South America Arbovirus Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Arbovirus Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Arbovirus Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Arbovirus Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Arbovirus Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Arbovirus Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Arbovirus Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Arbovirus Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By End User
  • 10.3.4. Egypt Arbovirus Testing Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Test Type
      • 10.3.4.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Arbovirus Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Becton Dickinson & Co
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (In case of listed)
  • 15.1.5. Recent Developments
  • 15.1.6. SWOT Analysis
• 15.2. bioMerieux SA
• 15.3. Abbott Laboratories Inc.
• 15.4. Quidel Corporation
• 15.5. OraSure Technologies, Inc.
• 15.6. Hologic Inc. (Gen Probe)
• 15.7. Cepheid (Danaher)
• 15.8. QIAGEN N. V.
• 15.9. F. Hoffmann-La Roche Ltd.
• 15.10. Bio-Rad Laboratories, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer